Skip to content
akaturk Academic measurement
Sign in Sign up

OpenAlex topic

Infections and bacterial resistance

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 1,543 works 16 author topics

Works

1,543 works

  1. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe 2012
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    No abstract yet.

  2. A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients 2009
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.8%

    BACKGROUND: Infections caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are increasing in frequency and are associated with high mortality rates. Circulation of CTX-M-type ESBLs in the community is of particular concern, because it may confound standard infection-control measures. METHODS…

  3. Widespread detection of PER 1 type extended spectrum beta lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey a nationwide multicenter study 1997
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.5%

    We studied the prevalence and molecular epidemiology of PER-1-type beta-lactamases among Acinetobacter, Klebsiella, and Pseudomonas aeruginosa strains isolated over a 3-month period in eight university hospitals from distinct regions of Turkey. A total of 72, 92, and 367 Acinetobacter, Klebsiella, and P. aeruginosa is…

  4. In vitro activities of non traditional antimicrobials alone or incombination against multidrug resistant strains of Pseudomonasaeruginosa and Acinetobacter baumannii isolated from intensive careunits 2006
    YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 94.9%

    No abstract yet.

  5. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units 2006
    YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 95.2%

    No abstract yet.

  6. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China 2020
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.3%

    No abstract yet.

  7. Evolution of antimicrobial resistance among Pseudomonas aeruginosa Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn NY 2007
    YÖKSİS OpenAlex top 10% OpenAlex 98.3%

    OBJECTIVES: To document resistance patterns of three important nosocomial pathogens, Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae, present in hospitals in Brooklyn, NY. METHODS: Susceptibility profiles of pathogens gathered during a surveillance study in 2006 were analysed and compared wit…

  8. Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections 2014
    YÖKSİS SJR Q1 JCR Q2 OpenAlex top 1% OpenAlex 99.1%

    No abstract yet.

  9. Task force on management and prevention of Acinetobacter baumannii infections in the ICU 2015
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.2%

    No abstract yet.

  10. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen 2004
    YÖKSİS SJR Q1 JCR Q3 OpenAlex top 10% OpenAlex 93.7%

    No abstract yet.

  11. Baran G, Erbay A, Bodur H, Ongürü P, Akinci E, Balaban N, Cevik MA. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis. 2008 Jan;12(1):16-21. doi: 10.1016/j.ijid.2007.03.005. Epub 2007 May 21. PMID: 17513154. 2024
    YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.7%

    OBJECTIVES: To identify the risk factors for nosocomial imipenem-resistant Acinetobacter baumannii (IRAB) infections. METHODS: A prospective case-control study, set in an 1100-bed referral and tertiary-care hospital, of all patients who had nosocomial A. baumannii infections between January 1 and December 31, 2004. On…

  12. Risk factors for nosocomial imipenem resistant Acinetobacter baumannii infections 2008
    YÖKSİS SJR Q1 JCR Q3 OpenAlex 88.7%

    OBJECTIVES: To identify the risk factors for nosocomial imipenem-resistant Acinetobacter baumannii (IRAB) infections. METHODS: A prospective case-control study, set in an 1100-bed referral and tertiary-care hospital, of all patients who had nosocomial A. baumannii infections between January 1 and December 31, 2004. On…

Academicians

16 academicians